Global Corticosteroids API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Corticosteroids API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Corticosteroids are a class of hormones that are naturally produced in the body or can be artificially synthesized for medicinal use. They have potent anti-inflammatory and immunosuppressive properties, and they are commonly used to treat a variety of medical conditions, including allergies, asthma, arthritis, and certain autoimmune disorders.

According to our (Global Info Research) latest study, the global Corticosteroids API market size was valued at US$ 2385 million in 2023 and is forecast to a readjusted size of USD 3527 million by 2030 with a CAGR of 6.0% during review period.

Global core manufacturers of Corticosteroids API include Pfizer CentreOne, EUROAPI and GlaxoSmithKline. The top three companies have a market share of about 28%. China is the world's largest market for Corticosteroids API with a market share of about 44%, followed by Europe and North America with a market share of 23% and 10%, respectively. In terms of product type, Dexamethasone Series is the largest segment, with a market share of approximately 34%. In terms of application, Oral Drugs is the largest downstream segment, accounting for approximately 49% of the market.

This report is a detailed and comprehensive analysis for global Corticosteroids API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Corticosteroids API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030

Global Corticosteroids API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030

Global Corticosteroids API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030

Global Corticosteroids API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Corticosteroids API

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Corticosteroids API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Teva Pharmaceutical Industries, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, Anuh Pharma, Symbiotec Pharmalab, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Corticosteroids API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others

Market segment by Application
Injectable Drugs
Oral Drugs
Topical Drugs
Inhaled Drugs

Major players covered
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Teva Pharmaceutical Industries
Hovione
Axplora
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Wellona Pharma
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Guangdong VTR BioTech
Zhejiang Xianju Xianle Pharmaceutical
Tianjin Pacific Pharmaceutical
Shandong Xinhua Pharmaceutica Group
Jiangsu Lianhuan Pharmaceutical
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Shandong Sito Bio-technology
Zhejiang Xianju Junye Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Corticosteroids API product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Corticosteroids API, with price, sales quantity, revenue, and global market share of Corticosteroids API from 2019 to 2024.

Chapter 3, the Corticosteroids API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Corticosteroids API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Corticosteroids API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Corticosteroids API.

Chapter 14 and 15, to describe Corticosteroids API sales channel, distributors, customers, research findings and conclusion.